| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.28 | 0.0002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |